Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe

Authors: Alison D Marshall, Evan B Cunningham, Stine Nielsen, Alessio Aghemo, Hannu Alho, Markus Backmund, Philip Bruggmann, Olav Dalgard, Carole Seguin-Devaux, Robert Flisiak, Graham R Foster, Liana Gheorghe, David Goldberg, Ioannis Goulis, Matthew Hickman, Patrick Hoffmann, Ligita Jancorienė, Peter Jarcuska, Martin Kåberg, Leondios G Kostrikis, Mihály Makara, Matti Maimets, Rui Tato Marinho, Mojca Matičič, Suzanne Norris, Sigurður Ólafsson, Anne Øvrehus, Jean-Michel Pawlotsky, James Pocock, Geert Robaeys, Carlos Roncero, Marieta Simonova, Jan Sperl, Michele Tait, Ieva Tolmane, Stefan Tomaselli, Marc van der Valk, Adriana Vince, Gregory J Dore, Jeffrey V Lazarus, Jason Grebely, on behalf of the International Network on Hepatitis in Substance Users (INHSU)

Journal: The Lancet Gastroenterology & Hepatology Year: 2018 Reference: 3(2):125-133

Read more >


Strategies for achieving universal access to hepatitis C virus prevention and care for people who inject drugs

Authors: Jason Grebely, Philip Bruggmann, Carla Treloar, Jude Byrne, Tim Rhodes, Gregory J. Dore, on behalf of the International Network for Hepatitis in Substance Users

Journal: International Journal of Drug Policy Year: 2015 Reference: 26:1039-1040

Read more >


Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs

Authors: Jason Grebely, Philip Bruggmann, Carla Treloar, Jude Byrne, Tim Rhodes, Gregory J. Dore, on behalf of the International Network for Hepatitis in Substance Users

Journal: International Journal of Drug Policy Year: 2015 Reference: 26:893-898

Read more >


Recommendations for the management of hepatitis C virus infection among people who inject drugs

Authors: Jason Grebely, Geert Robaeys, Philip Bruggmann, Alessio Aghemo, Markus Backmund, Julie Bruneau, Jude Byrne, Olav Dalgard, Jordan J. Feld, Margaret Hellard, Matthew Hickman, Achim Kautz, Alain Litwin, Andrew R. Lloyd, Stefan Mauss, Maria Prins, Tracy Swan, Martin Schaefer, Lynn E. Taylor, Gregory J. Dore, on behalf of the International Network for Hepatitis in Substance Users

Journal: International Journal of Drug Policy Year: 2015 Reference: 26:1028-1038

Read more >


Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C

Authors: Jason Grebely, Tracy Swan, Matthew Hickman, Julie Bruneau, Philip Bruggmann, Olav Dalgard, Alain Litwin, Markus Backmund, Gregory J. Dore, on behalf of theInternational Network for Hepatitis in Substance Users

Journal: Journal of Hepatology Year: 2017 Reference: 66:1099-1103

Read more >


Excluding people who use drugs or alcohol from access to hepatitis C treatments – Is this fair, given the available data?

Authors: Jason Grebely, Bridget Haire, Lynn E. Taylor, Paul Macneill, Alain H. Litwin, Tracy Swan, Jude Byrne, Jules Levin, Philip Bruggmann, Gregory J. Dore, On behalf of theInternational Network for Hepatitis in Substance Users

Journal: Journal of Hepatology Year: 2015 Reference: 63(4):779-782

Read more >


Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all

Authors: Jason Grebely, Behzad Hajarizadeh, Jeffrey V. Lazarus, Julie Bruneau, Carla Treloare, on behalf of the International Network on Hepatitis in Substance Users

Journal: The International Journal of Drug Policy Year: 2019 Reference: 72:1-10

Read more >


Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy

Authors: Jason Grebely, Julie Bruneau, Philip Bruggmann, Magdalena Harris, Matthew Hickman, Tim Rhodes, Carla Treloar, on behalf of the International Network on Hepatitis in Substance Users

Journal: International Journal of Drug Policy Year: 2017 Reference: 47:26-33

Read more >


Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs

Authors: Emma Day, Tina Broder, Julie Bruneau, Sally Cruse, Melisa Dickie, Suzanne Fish, Celine Grillon, Niklas Luhmann, Kate Mason, Elizabeth McLean, Stacey Trooskin, Carla Treloar, Jason Grebely

Journal: International Journal of Drug Policy Year: 2019 Reference: 66:87-93

Read more >


Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework

Authors: Emma Day, Margaret Hellard, Carla Treloar, Julie Bruneau, Natasha K. Martin, Anne Øvrehus, Olav Dalgard, Andrew Lloyd, John Dillon, Matt Hickman, Jude Byrne, Alain Litwin, Mojca Maticic, Philip Bruggmann, Havard Midgard, Brianna Norton, Stacey Trooskin, Jeffrey V. Lazarus, Jason Grebely

Journal: Liver International Year: 2019 Reference: 39:20-30

Read more >


Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs

Authors: Jason Grebely, Julie Bruneau, Jeffrey V. Lazarus, Olav Dalgard, Philip Bruggmann, Carla Treloar, Matthew Hickman, Margaret Hellard, Teri Roberts, Levinia Crooks, Håvard Midgard, Sarah Larney, Louisa Degenhardt, Hannu Alho, Jude Byrne, John F. Dillon, Jordan J. Feld, Graham Foster, David Goldberg, Andrew R. Lloyd, Jens Reimer, Geert Robaeys, Marta Torrens, Nat Wright, Icro Maremmani, Brianna L. Norton, Alain H. Litwin, Gregory J. Dore, on behalf of the International Network on Hepatitis in Substance Users

Journal: The International Journal of Drug Policy Year: 2017 Reference: 47:51-60

Read more >